slideshow15 slideshow16 Screenshot 2 Screenshot 3 Screenshot 4 Screenshot 5 Screenshot 6

In the News

Moss & Gilmore obtains $4.2 Million for Client in FCA Whistleblower Lawsuit Alleging Kick-Back Arrangements Leading to Indictment of Former Georgia Insurance Commissioner John Oxendine for Healthcare Fraud and Money Laundering

ATLANTA, Georgia (May 24, 2022)

John Oxendine was indicted on May 17, 2022 on charges that he conspired to commit health care fraud. This indictment is the fourth prosecution of the fraud uncovered and brought to light by Moss & Gilmore client Dr. Myron Jones’ qui tam action, with the prior three prosecutions resulting in a $3 million settlement against Dr. Gallups, a $1.2 million settlement against Entellus, and Dr. Gallups’ guilty plea for criminal health care fraud.

Moss & Gilmore Press Release

DOJ Press Release

Law360 News Article

AJC News Article

DOJ Press Release - Former Georgia Ins. Commissioner John Oxendine charged with health care fraud and money laundering scheme

Moss & Gilmore Client CharterUp Named to Deloitte’s Technology Fast 500 Top 10 Companies

ATLANTA, Georgia (Nov. 18, 2020)

Moss & Gilmore LLP is pleased to announce that client, CharterUp (, has been ranked Number 8 in Deloitte’s Technology Fast 500 Top 10 companies for 2020 in the Software and SaaS sector. CharterUp is a leader in logistics, executive-level transportation services, and private motor coach acquisitions.

Deloitte 2020 North America Technology Fast 500 Rankings

Atlanta Business Chronicle Article

Moss & Gilmore Act as Co-Lead Counsel In $10.02 Million Settlement to Resolve Defective Concrete Class Action Suit Against Argos

ATLANTA, Georgia (Sept. 21, 2020)

Press Release

Second Amended Complaint

Order Preliminarily Approving Class Action Settlement and Conditionally Certifying Settlement Class

Universal Health Services Pays $117 Million to Settle 18 Whistleblower Cases Involving Medically Unnecessary Inpatient Behavioral Health Services

ATLANTA, Georgia (July 10, 2020)

Moss & Gilmore LLP represented one group of whistleblowers in this settlement, which also included claims for retaliation which were also resolved.

Moss & Gilmore Press Release

DOJ Press Release

Atlanta Journal Constitution news article

Wall Street Journal news article

Moss & Gilmore obtains $16 Million settlement in a whistleblower lawsuit for improper cardiac and vascular short stay admissions and anti-kickback violations.

ATLANTA, Georgia (June 25, 2020)

Moss & Gilmore Press Release

DOJ Press Release

Atlanta Journal Constitution news article

Atlanta Business Chronicle news article

Law360 news article

DOTmed news article

Moss & Gilmore Represents Management of Large, Well Known and Established New York City Based Money Manager and Registered Investment Adviser in Buy-Out

NEW YORK, New York (April 1, 2019)

The transaction team was led by Raymond L. Moss and Michael P. Gilmore.

Moss & Gilmore Guide JetSuite in Strategic Expansion Capital Investment by Qatar Airways and Follow-On By JetBlue

ATLANTA, Georgia (April 10, 2018) -

Qatar Airways made a strategic equity investment in JetSuite, Inc., one of the largest and fastest growing private jet companies in the U.S. Certain other investors, including JetBlue Airways, also participated.

Click here for PR Newswire press release

Click here for Forbes article

Moss & Gilmore Client Kamal Al-Sultan Named “Whistleblower of the Year” by Taxpayers Against Fraud For False Claims Act U.S. Military Food Fraud Case During Iraq Wars

ATLANTA, Georgia (Nov. 13, 2017) – Moss & Gilmore LLP announced today on behalf of their client Kamal Al-Sultan, a Kuwaiti businessman and U.S. military contractor of base camp logistics and support, that he was named “2017 Whistleblower of the Year” at the Taxpayers Against Fraud Education Fund ("TAF”) annual Awards Dinner on November 2, 2017 in Washington, D.C.  

Click here for the Press Release

Click here for 2017 Whistleblower of the Year Acceptance Speech audio recording

Moss & Gilmore Obtain $7.9 Million Settlement In FCA Whistleblower Lawsuit For Improper Radiation Oncology and E.R. Services; including payment of $850,000 for Whistleblower Retaliation Claim

ATLANTA, Georgia (Sept. 27, 2017) – Moss & Gilmore LLP announced today on behalf of their client Linda Jainniney, a former radiation oncology manager for AnMed Health, an affiliate of Carolina Health Care System (“CHS”), the settlement of a whistleblower lawsuit. AnMed Health will pay the federal government $7,073,000 to resolve allegations by the United States that it knowingly violated Federal law by, among other things, submitting claims, including lack of physician supervision by AnMed's radiation oncologists and upcoding nurse's services as if the physician performed the procedure, to Medicare and other federal payors.

Moss & Gilmore Press Release

Fulton County Daily Report

Georgia DOJ Press Release

South Carolina DOJ Press Release

Report on Medicare Compliance

Moss & Gilmore Obtain $95 Million Settlement In FCA Whistleblower Lawsuit For Overcharging and Kickbacks for U.S. Soldiers’ Food During Iraq Wars

ATLANTA, Georgia (May 26, 2017) – Moss & Gilmore LLP announced today on behalf of their client Kamal Al-Sultan, a Kuwaiti businessman and U.S. military contractor of base camp logistics and support, the settlement of a whistleblower lawsuit initiated by Mr. Al-Sultan in 2005. The suit alleged fraud on the part of publically traded Kuwaiti based Agility Public Warehousing Company “(“PWC”) and its affiliate, The Sultan Center (“TSC”). PWC was the prime vendor to feed U.S. and coalition troops in Iraq, Iran and Jordan from 2003–2010, pursuant to $8.5 billion worth of prime-vendor food contracts.    

Moss & Gilmore Press Release

DOJ Main Justice Press Release

Georgia DOJ Press Release

Atlanta Journal Constitution Article

Firm Overview

Moss & Gilmore LLP is an Atlanta and New York-based law firm with significant experience in numerous areas of practice. We are accomplished advocates in both the boardroom and the courtroom, handling sophisticated commercial transactions and complex litigation. 

Our clients include leading domestic and foreign multinational corporations, major financial institutions, broker-dealers, investment advisers, investment funds, and public and privately-held companies. We serve start-up ventures and individuals as well. Other lawyers and law firms often retain our services themselves and refer their clients to us when conflicts arise. 

We have substantial experience representing investors, broker-dealers and funds in investment-related disputes. The firm also represents corporate and individual whistleblowers in state and federal false claims, and SEC, CFTC and IRS whistleblower actions in various industries including securities, health care and defense contracting. We represent employees and third parties in related wrongful termination claims related to reporting or seeking to prevent fraud.

The firm is composed of lawyers who have worked at some of the largest and most prestigious law firms in the country. In handling matters, partners not only provide direct strategic guidance, but also perform the work themselves. As a result, matters are not staffed with layers of associates and are completed in a timely and cost-effective manner. The firm utilizes state-of-the-art technology to render excellent client service.

We value exceptional lawyers who function collaboratively as well as independently. Our attorneys approach their work with enthusiasm, energy and commitment to achieving our clients' goals.

Blog Posts

False Claims Act Settlements and Judgments for Fiscal Year 2022 Exceed $2 Billion

The Department of Justice (DOJ) announced on February 7, 2023 that settlements and judgments under the False Claims Act (FCA) exceeded $2.2 billion in the fiscal year ending Sept. 30, 2022, with $1.7 billion in healthcare collections making up the bulk of the FCA settlements and judgments, and included fraud in Medicaid and the Medicare Advantage program, overpayments, unnecessary services and substandard care and unlawful kickbacks. READ MORE

New AML Whistleblower Law

On December 23, 2022, Congress agreed to include the AML Whistleblower Improvement Act as part of the Omnibus Budget signed into law by President Biden. A new era of robust transnational whistleblower protections commenced. Whistleblowers from around the world now have a pathway to combat corruption effectively. For the first time in history, whistleblowers from any country have the right to anonymously and confidentially report money laundering and sanctions-busting to the U.S. Departments of Justice or Treasury. If their information results in a successful prosecution, they could receive between 10-30% of the sanctions obtained by the wrongdoers.

SEC Exceeds $1 Billion in Whistleblower Awards

The Securities and Exchange Commission (“SEC”) announced that its whistleblower program has now paid more than $1 billion in awards to 207 whistleblowers since its first award in 2012, and has paid over $500 million to 101 whistleblowers in fiscal year 2021 alone. The awards can range from 10% to 30% of the money collected by the SEC when the sanctions exceed $1 million and are funded by the sanctions and not by investors who were harmed. Information provided by whistleblowers since the program began has resulted in more than $4.8 billion being collected in financial remedies.

SEC Slightly Increases Dollar Amount Thresholds for “Qualified Client”

The Securities and Exchange Commission (“SEC”) has slightly adjusted the dollar amount thresholds for assets-under-management and net worth tests for a “qualified client”. Registered investment advisers have generally been prohibited from charging a client a performance fee unless the client is a qualified client, defined to include a client with (a) at least $1 million under management with the investment adviser or (b) a net worth of more than $2.1 million (the “net worth test”). The SEC has issued an Order increasing the assets-under-management threshold to $1.1 million and the net worth test to $2.2 million. The Order will be effective as of August 16, 2021.

Record Number of Health Fraud Cases Reported by DOJ

The DOJ opened over 900 False Claims cases last year involving healthcare fraud and is focusing on misuse of electronic health records, contribution to the opioid epidemic, abuse of senior citizens, manipulation of Medicare’s managed care program, and improper claims of COVID-19 relief funds. The False Claims Act (FCA) is the DOJ’s predominant tool in companies’ liability for defrauding the government and in recovering taxpayer money, and 366 FCA matters—including 265 healthcare fraud cases—were settled in 2020.


Selected Recent Developments in Indemnification and Advancement Rights for Officers, Directors, Investment Managers of Hedge Funds, and Other Related Parties: Who Will Pick Up the Bill and When?

Practising Law Institute; Securities Arbitration the Market Meltdown Era: Achieving Fairness in Perception and Reality (Volume Two; 2009)

The U.S. Patriot Act and Related Domestic and International Anti-Money Laundering Regulations, With a Special Focus on Switzerland: Legal and Business Implications

Practising Law Institute; Securities Arbitration Handbook (2004 ed.)

New CFTC Flexibility for Hedge Fund Managers

ABANA Review (Fall 2003)

The Wall Street Analyst: Rise and Fall of a Rock Star

Practising Law Institute; Securities Arbitration Handbook (2002 ed.)

Liability Of Clearing Firms: Traditional And Developing Perspectives

Practising Law Institute; Securities Arbitration Handbook (1998 ed.)

Email Us For Consultation Call (678) 381-8601

Practice Areas

False Claims Act, CFTC, SEC and IRS Whistleblower Litigation Broker-Dealer and Other Investment Professional Disputes Business Litigation and Alternative Dispute Resolution Corporate, Securities, and Mergers and Acquisitions

Contact Us

Atlanta Office

3630 Peachtree Road
Suite 1025
Atlanta, Georgia 30326
Telephone: (678) 381-8600
Facsimile: (815) 364-0515

New York City Office

30 Wall Street,
8th Floor
New York, New York 10005-2205
Telephone: (212) 709-8255
Facsimile: (815) 364-0515

Long Island Office

129 Third Street
Mineola, New York 11501
Telephone: (516) 739-9009
Facsimile: (516) 739-9011